BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8102609)

  • 1. Early steps of the P-glycoprotein expression in cell cultures studied with vital fluorochrome.
    Egudina SV; Stromskaya TP; Frolova EA; Stavrovskaya AA
    FEBS Lett; 1993 Aug; 329(1-2):63-6. PubMed ID: 8102609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
    Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
    Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
    Twentyman PR; Rhodes T; Rayner S
    Eur J Cancer; 1994; 30A(9):1360-9. PubMed ID: 7999426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In archaebacteria, there is a doxorubicin efflux pump similar to mammalian P-glycoprotein.
    Miyauchi S; Komatsubara M; Kamo N
    Biochim Biophys Acta; 1992 Oct; 1110(2):144-50. PubMed ID: 1356441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
    Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
    J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
    Nare B; Prichard RK; Georges E
    Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between rhodamine 123 transport, cell volume, and ion-channel function of P-glycoprotein.
    Altenberg GA; Vanoye CG; Han ES; Deitmer JW; Reuss L
    J Biol Chem; 1994 Mar; 269(10):7145-9. PubMed ID: 7510282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane.
    Altenberg GA; Vanoye CG; Horton JK; Reuss L
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4654-7. PubMed ID: 7910961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of P glycoprotein activity on normal and leukemic CD34+ cells.
    Drenou B; Fardel O; Amiot L; Fauchet R
    Leuk Res; 1993 Dec; 17(12):1031-5. PubMed ID: 7504150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance-related proteins in primary choroidal melanomas and in vitro cell lines.
    van der Pol JP; Blom DJ; Flens MJ; Luyten GP; de Waard-Siebinga I; Koornneef L; Scheper RJ; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2523-30. PubMed ID: 9375571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid stimulation of rhodamine 123 efflux from multidrug-resistant KB cells by progesterone.
    Jancis EM; Chen HX; Carbone R; Hochberg RB; Dannies PS
    Biochem Pharmacol; 1993 Nov; 46(9):1613-9. PubMed ID: 7902090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of P-glycoprotein-dependent drug transport in isolated rat hepatocytes using rhodamine 123.
    Chieli E; Santoni Rugiu E; Cervelli F; Paolicchi A; Tongiani R
    Cell Biol Toxicol; 1993; 9(3):235-41. PubMed ID: 7905358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione S-transferases and P-glycoprotein in normal rat hepatocytes and hepatoma cells: analysis using flow cytometry.
    Mehta R; Davis HG; Laver GW; Rowsell PR; Bondy GS
    Cancer Lett; 1994 Sep; 84(2):163-72. PubMed ID: 7915642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
    Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
    Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter.
    Weaver JL; Szabo G; Pine PS; Gottesman MM; Goldenberg S; Aszalos A
    Int J Cancer; 1993 May; 54(3):456-61. PubMed ID: 7685326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the interaction of the multidrug-resistance phenotype with the polypeptide ionophore gramicidin D via functional channel formation.
    Assaraf YG; Borgnia MJ
    Eur J Biochem; 1994 Jun; 222(3):813-24. PubMed ID: 7517866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.
    Eytan GD; Regev R; Oren G; Hurwitz CD; Assaraf YG
    Eur J Biochem; 1997 Aug; 248(1):104-12. PubMed ID: 9310367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of P-glycoprotein function using rhodamine 123.
    Pétriz J; García-López J
    Leukemia; 1997 Jul; 11(7):1124-30. PubMed ID: 9205001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two multidrug-resistant Friend leukemic cell lines selected with different drugs exhibit overproduction of different P-glycoproteins.
    Savaraj N; Lampidis TJ; Zhao JY; Wu CJ; Teeter LD; Kuo MT
    Cancer Invest; 1994; 12(2):138-44. PubMed ID: 7907527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staining with Hoechst 33342 and rhodamine 123: an attempt to detect multidrug resistant phenotype cells in leukemia.
    Lahmy S; Lautier D; Canitrot Y; Laurent G; Salmon JM
    Leuk Res; 1993 Dec; 17(12):1021-9. PubMed ID: 7902473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.